Beneficial Effects of ε-Viniferin on Obesity and Related Health Alterations.
Saioa Gomez ZoritaIñaki Milton-LaskibarItziar EseberriPauline BeaumontArnaud CourtoisStephanie KrisaMaria Puy PortilloPublished in: Nutrients (2023)
Viniferin is a phenolic compound belonging to the group of stilbenoids. In particular, ε-viniferin is a dimer of resveratrol, found in many plant genders, among which grapes ( Vitis vinifera ) are a primary source. Due to the fact that ε-viniferin is mainly present in the woody parts of plants, their use as a source of this bioactive compound is a very interesting issue in a circular economy. Both, in vitro studies carried out in pre-adipocytes and mature adipocytes and in vivo studies addressed in mice show that ε-viniferin is able to reduce fat accumulation. Moreover, it prevents the development of some obesity co-morbidities, such as type 2 diabetes, dyslipidemias, hypertension and fatty liver. ε-viniferin can be absorbed orally, but it shows a very low bioavailability. In this scenario, further research on animal models is needed to confirm the effects reported in a great number of studies; to determine which metabolites are involved, including the main one responsible for the biological effects observed and the mechanisms that justify these effects. In a further phase, human studies should be addressed in order to use ε-viniferin as a new tool for obesity management, as a nutraceutical or to be included in functional foods.
Keyphrases
- type diabetes
- high fat diet induced
- insulin resistance
- adipose tissue
- metabolic syndrome
- weight loss
- case control
- healthcare
- blood pressure
- weight gain
- endothelial cells
- mental health
- public health
- cardiovascular disease
- body mass index
- risk assessment
- climate change
- glycemic control
- social media
- fatty acid
- pluripotent stem cells